A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 21, 2008

Primary Completion Date

March 30, 2012

Study Completion Date

March 30, 2012

Conditions

Squamous Cell Carcinoma of Head and Neck

Interventions

DRUG

Panitumumab

This is a PK study comparing Panitumumab plus Chemotherapy to Chemotherapy alone

DRUG

Cisplatin

This is a PK study comparing Panitumumab plus Chemotherapy to Chemotherapy alone

DRUG

5FU

This is a PK study comparing Panitumumab plus Chemotherapy to Chemotherapy alone